GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Ending Cash Position

ANL (Adlai Nortye) Ending Cash Position : $0.00 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Ending Cash Position?

Adlai Nortye's Ending Cash Position for the quarter that ended in Jun. 2024 was $0.00 Mil.

Adlai Nortye's quarterly Ending Cash Position declined from Jun. 2023 ($60.03 Mil) to Dec. 2023 ($0.00 Mil) but then stayed the same from Dec. 2023 ($0.00 Mil) to Jun. 2024 ($0.00 Mil).

Adlai Nortye's annual Ending Cash Position declined from Dec. 2021 ($64.13 Mil) to Dec. 2022 ($42.76 Mil) but then increased from Dec. 2022 ($42.76 Mil) to Dec. 2023 ($91.49 Mil).

Adlai Nortye Ending Cash Position Historical Data

The historical data trend for Adlai Nortye's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Ending Cash Position Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Ending Cash Position
64.13 42.76 91.49

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Ending Cash Position Get a 7-Day Free Trial - 59.84 60.03 - -

Adlai Nortye Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Adlai Nortye's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=42.758+48.734
=91.49

Adlai Nortye's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00

Adlai Nortye Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Adlai Nortye Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Ending Cash Position
Comparable Companies
MGTX KALV JANX AVTE ABUS VYGR BLUE AGEN FUSN CRBU OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N2U0:Germany
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Website
https://www.adlainortye.com
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.